Next-generation humanized mouse models allow immuno-oncology researchers to study novel therapeutics in the context of a more fully-functional immune system, improving the speed and translatability of their research.
Part II of the series expands into the cutting-edge possibilities supported by models endogenously expressing human cytokines.
Download Webinar